Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails
Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to assess the safety of NAB001 for topical treatment of mild
to moderate distal onychomycosis of the toenails over 52 weeks and to compare the efficacy of
NAB001 to vehicle alone at the end of the study (Week 56) after treating for 52 weeks.